This site is intended for healthcare professionals only

New Publication Update: Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

With

Dr Stuart Connolly

Approx. time required 30 mins
Watch now

Extended betrixaban in the medically ill: a comparison of fatal or irreversible events with standard treatment

Dr Cohen

With

Dr Alexander Cohen

Approx. time required 30 mins
Watch now

Dual antithrombotic therapy after percutaneous coronary intervention

With

Dr Christopher Cannon

Approx. time required 30 min
Watch now

Reversing anticoagulation: the latest results from the RE-VERSE AD trial

With

Dr Charles Pollack

Approx. time required 30 min
Watch now

Therapy with non-vitamin K oral anticoagulants (NOACs) gives us with the best opportunity that we have had to increase anticoagulation for patient with at-risk atrial fibrillation and greatly reduce stroke burden that complicates this arrhythmia.

Professor John Camm, NOAC Faculty member